Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person9
Medicus Pharma Ltd.
Company
Nasus Pharma Ltd
Company
Kairos Pharma, LTD.
Company
UroGen Pharma Ltd.
Company
Medi UK Ltd
Company · 02110690
Alpha Tau Medical Ltd.
Company
MediWound Ltd.
Company
BeOne Medicines Ltd.
Company
IceCure Medical Ltd.
Company
Primary record15
Medicus Pharma Ltd. filed 8-K
Item 7.01 Regulation FD Disclosure. On November 4, 2026, Medicus Pharma Ltd. (the "Company" or "Medicus") issued a press release announcing a non-binding letter of intent in connection with a potential business combinati
Medicus Pharma Ltd. filed DEF 14A
SEC form DEF 14A filed by Medicus Pharma Ltd. (CIK 1997296) on 2026-10-30.
Medicus Pharma Ltd. filed 8-K
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On October 23, 2026, Medicus Pharma Ltd. (the "Company") received written notice (the "Compliance Notice") fr
Medicus Pharma Ltd. filed 8-K
Item 3.03 Material Modification to Rights of Security Holders Medicus Pharma Ltd. (the "Company") effected a 1-for-50 share consolidation (the "Share Consolidation") of the Company's issued and outstanding common shares,
Medicus Pharma Ltd. filed SCHEDULE 13G/A
0000950142-26-002781.txt : 20261016 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0002050471 XXXXXXXX LIVE 2 Common Shares, no par value 09/30/2026 0001997296 Medicus Pharma Ltd. 58471K301 300 CONSHOHOCKEN STATE
Medicus Pharma Ltd. filed 8-K
Item 8.01 Other Events. Share Consolidation Medicus Pharma Ltd. (the "Company") today announced that it will effect a fifty-to-one consolidation (the "Share Consolidation") of the Company's common shares, no par value (t
Medicus Pharma Ltd. filed SCHEDULE 13D
0000950142-26-002546.txt : 20260914 SCHEDULE 13D 1 primary_doc.xml X0202 SCHEDULE 13D 0001660525 XXXXXXXX LIVE Common shares, no par value 09/04/2026 false 0001997296 58471K202 Medicus Pharma Ltd. 300 Conshohocken State
Medicus Pharma Ltd. filed 8-K
Item 1.02. Termination of a Material Definitive Agreement. On September 11, 2026, Medicus Pharma Ltd. (the "Company") and YA II PN, LTD. ("Yorkville") mutually agreed to terminate the Standby Equity Purchase Agreement, d
Medicus Pharma Ltd. filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. On September 4, 2026, Medicus Pharma Ltd. (the "Company") awarded cash bonuses in the aggregate amount of approximately $1.45 million to certain officers and employees o
Medicus Pharma Ltd. filed 4
SEC form 4 filed by Medicus Pharma Ltd. (CIK 1997296) on 2026-09-08.
Medicus Pharma Ltd. filed 4
SEC form 4 filed by Medicus Pharma Ltd. (CIK 1997296) on 2026-09-08.
Medicus Pharma Ltd. filed 4
SEC form 4 filed by Medicus Pharma Ltd. (CIK 1997296) on 2026-09-08.
Medicus Pharma Ltd. filed 4
SEC form 4 filed by Medicus Pharma Ltd. (CIK 1997296) on 2026-09-08.
Medicus Pharma Ltd. filed 4
SEC form 4 filed by Medicus Pharma Ltd. (CIK 1997296) on 2026-09-08.
Medicus Pharma Ltd. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On September 2, 2026, Medicus Pharma Ltd. (the "Company"), through its wholly owned subsidiary, Medicus Pharma Inc., entered into a Co-Development and License Agreem